“That’s Like an Act of Suicide” Patients’ Attitudes Toward Deactivation of Implantable Defibrillators by Goldstein, Nathan E. et al.
“That’s Like an Act of Suicide” Patients’ Attitudes
Toward Deactivation of Implantable Defibrillators
Nathan E. Goldstein, MD
1,2, Davendra Mehta, MD, PhD
3, Saima Siddiqui, MPH
1,
Ezra Teitelbaum, BA
1, Jessica Zeidman, BA
1, Magdelena Singson, RN, NP
3, Elena Pe, RN, NP
3,
Elizabeth H. Bradley, PhD
4, and R. Sean Morrison, MD
1,2
1Department of Geriatrics, Mount Sinai School of Medicine, Box 1070, One Gustave Levy Place, New York, NY 10029, USA;
2Geriatric Research
Education and Clinical Care Center, James J. Peters Veterans Affairs Health System, Bronx, New York, NY, USA;
3Department of Medicine,
Mount Sinai School of Medicine, New York, NY, USA;
4Department of Epidemiology and Public Health and Robert Wood Johnson Clinical
Scholars Program, Yale School of Medicine, New Haven, CT, USA.
OBJECTIVE: To understand potential patient barriers
to discussions about implantable cardioverter defibril-
lator (ICD) deactivation in patients with advanced
illness.
DESIGN: Qualitative focus groups.
PARTICIPANTS: Fifteen community-dwelling, ambula-
tory patients with ICDs assigned to focus groups based
on duration of time since implantation and whether
they had ever received a shock from their device.
APPROACH: A physician and a social worker used a
predetermined discussion guide to moderate the
groups, and each session was audiotaped and subse-
quently transcribed. Transcripts were analyzed using
the method of constant comparison.
RESULTS: No participant had ever discussed deactiva-
tion with their physician nor knew that deactivation
was an option. Patients expressed a great deal of
anxiety about receiving shocks from their device. Parti-
cipants discussed why they needed the device and
expressed desire for more information about the device;
however, they would not engage in conversations about
deactivating the ICD. One patient described deactiva-
tion “like an act of suicide” and all patients believed that
the device was exclusively beneficial. Patients also
expressed a desire to have their physician make the
decision about deactivation.
CONCLUSIONS: None of the patients in our study knew
that they might need to deactivate their ICD as their
health worsens. These community-dwelling outpatients
were not willing to discuss the issue of ICD deactivation
and their attitudes about deactivation might impede
patients from engaging in these conversations. These
findings are in contrast to findings in other advance
care planning research and may be related to the
unique nature of the ICD.
KEY WORDS: palliative care; advanced technology; communication;
patient–physician relationship; implantable cardioverter defibrillator.
J Gen Intern Med 23(Suppl 1):7–12
DOI: 10.1007/s11606-007-0239-8
© Society of General Internal Medicine 2007
INTRODUCTION
An implantable cardioverter defibrillator (ICD) is a device
implanted in a patient’s chest to monitor the heart rhythm
and deliver shocks to terminate potentially lethal arrhythmias.
Although ICDs reduce sudden cardiac death,
1–4 patients
ultimately die from either heart failure or another disease. As
a patient’s disease worsens, physiologic changes (intrinsic and
extrinsic to the heart) may affect the cardiac conduction
system, leading to more arrhythmias and increasing the
frequency of shocks. Because ICD shocks can cause pain and
anxiety and may not prolong a life of acceptable quality,
5–7 it is
appropriate to consider ICD deactivation as a patient’s clinical
status worsens and death is near. Previous work has shown
that clinicians and patients rarely engage in discussions about
deactivating ICDs and most devices remain active until death.
8
Because of this, many patients may receive shocks in the final
hours to minutes of life, an unpleasant situation that causes
suffering to both patients and their families.
8
Patient-related barriers to ICD deactivation discussions
have not been previously studied. Given the expanding indica-
tions for ICD implantation,
1–4,9,10 the issue of device deactiva-
tion will become more relevant as the population ages. Under
current Medicare criteria, approximately 3–4 million patients
are currently eligible to receive this device.
4,11–13 Ultimately, all
patients with an ICD will die, and therefore, it seems prudent
to better understand their wishes with respect to the role the
device will play in their future lives.
The purpose of this study was to identify barriers that
impede patients from discussing deactivation of their ICD near
the end of life. Because a traditional, closed-ended survey
instrument might miss the nuances and intricacies that are
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7key to understanding these conversations, we chose a quali-
tative method of using open-ended questions to conduct initial
explorations.
14–16 This method is more suited for understand-
ing the complexity of patients’ experiences and the role of these
devices in their lives.
METHODS
Study Design and Sample
We conducted a qualitative study using focus groups of
patients with ICDs. Patients were drawn from an outpatient
electrophysiology clinic at an academic medical center that
implants over 100 ICDs every year. All patients with ICDs who
came to the clinic between June and July 2005 were
approached by a member of the research team during their
regularly scheduled follow-up visit and asked if they would be
willing to participate in a “project discussing patients’ percep-
tions and attitudes about their ICD.” Potential participants
were told that this was a research project and was not meant
to be a support or informational group.
Patients were eligible if they had an ICD, their primary
language was English, were cognitively intact as determined by
a score of 8 or greater on the short portable mental status
questionnaire,
17 and were able to return to the medical center
at a later date to participate in the focus group. Participants
were compensated for their time ($20) and transportation costs
to the medical center (round-trip bus/subway fare) and were
provided refreshments during the course of the focus groups.
Patients were assigned to one of four groups grouped based
on the length of time since implantation and whether they had
received a shock as follows: patients who had their device for
less than 1 year and who had not received a shock, patients
who had their device for 1 year or more and who had not
received a shock, patients who had their device for less than
1 year and who had received a shock, and patients who had
their device for a year or more and had received a shock. We
refer to those patients who had their device a year or more as
“ICD>1 year.” The differentiation point for time since implant
was 1 year, as this is the length of time that has been shown to
be necessary for patients to adjust psychologically to these
devices.
7,18,19 Based on our clinical experience, we believed
that having received shocks would affect how patients might
make future decisions about their ICD; thus, we divided
groups into those patients who had never received a shock
and those patients who had.
Data Collection
The first author and a PhD-level social worker moderated all
focus groups. The social worker has had additional specialized
training in psychoanalysis, as well as experience in running
focus groups for health research purposes. Neither moderator
had direct patient care responsibilities for any of the patients
who were enrolled in the groups and had never met any of
them before enrolling them in the study. The moderators used
a predetermined guide (Table 1), which had been created by
the investigators based on their clinical experience with this
issue and their expertise in qualitative analyses. The guide
began by asking patients to explain their understanding of why
they needed an ICD. Next, patients were asked what they
understood about their ICD and its role in their health and
medical care. In addition, participants were asked how this
role might change in the future if/when their health worsened.
Finally, the moderators described two hypothetical scenarios,
both of which ended in the participant’s death. In one scenario,
participants would leave the device active and possibly receive
shocks as they were dying. In the other, the device would be
deactivated and the patient would not receive shocks. (Of note,
many ICDs are multifunctional devices that may also perform
a pacing or resynchronization function. For purposes of this
discussion, the term deactivation only refers to turning off the
shocking function of a defibrillator.) Subjects who came to the
sessions spoke readily, and were neither angered nor
concerned when the topic of their own mortality was discussed
despite not having been told in advance that the group would
focus on the potential for their health to worsen in the future.
Data Analysis
We used the constant comparative method
20,21 of qualitative
data analysis to develop and implement consistent and
comprehensive coding of the open-ended data. This method
employs a process in which quotations or observations are
catalogued into iteratively developed themes. The first tran-
script is analyzed and divided into passages relating to
individual concepts. Subsequent transcripts are then analyzed
and portions of these are compared to the previously analyzed
data to determine whether the same concepts are apparent.
New codes are added as needed until no new concepts emerge
with successive interviews (i.e., thematic saturation).
All focus groups were audiotaped and transcribed. The
transcripts were independently reviewed and coded by two of
the investigators (NG and JZ) who met to discuss the interviews
and the coding structure. In the rare cases where there were
discrepancies in the coding of a passage (which occurred fewer
than five times in the analysis of the data), the two investigators
brought in a third investigator (RSM) and the three came to a
negotiated consensus through further discussion of the content
and its overall context, as recommended by experts in qualitative
Table 1. Outline of Prompts for Facilitating Discussion for Focus
Groups of Patients with ICDs
Prompts
Tell me about the circumstances under which you needed your ICD—
why was device implanted? Did any patient have a history of sudden
death/syncope, or were all devices implanted for prophylaxis?
Tell me what you understand about your ICD and its role in your health
and medical care now. How will this role change in the future if/when
your health worsens?
Sometimes when a patient’s heart becomes very sick, the person can be
shocked often. In this case, some people choose to consider having
their ICD turned off. Tell me what you think about this.—Probe to see
if patients knew this was an option, their reaction to this information,
and if this has ever been discussed with them.
Would you ever consider having your ICD turned off? Tell me more
about the circumstances under which you would consider having it
turned off.—Probe to identify how patients consider benefits/burdens
and how these considerations compare to other medical devices. If
issue of quality vs quantity of life has not been raised yet, raise now.
Pretend that in the future you develop a very bad disease. In one
scenario, your doctor would turn off your ICD and you would die and
in the other scenario you would receive several shocks before you die.
In either case, unfortunately, you would die. How would this change
your thinking about your ICD?
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22 The group determined by consensus at which point
thematic saturation had been reached.
After analyzing the patients’ descriptions of why they
needed an ICD, the two investigators categorized the indica-
tions for device implantation as either primary prevention
(patients at risk for sudden cardiac death) or secondary
prevention (patients with a history of sudden cardiac death).
There were no discrepancies between the investigators in these
determinations. The Institutional Review Board at Mount Sinai
exempted this project from review because subjects did not
identify themselves during the course of the focus groups and
audiotapes and transcripts could not be linked to the individ-
ual subjects’ identities.
RESULTS
A total of 34 patients with ICDs were approached to participate
and 15 were enrolled. Of the 19 patients who were approached
but not enrolled, three refused and 16 could not return to the
medical center on the particular date specified for their focus
group. Nonparticipants did not differ from those who partici-
pated by age, sex, education, or time since implant (p>0.05).
The 15 participants were divided into three focus groups (ICD<
1 year, never shocked; ICD>1 year, never shocked; and ICD>
1 year, had received shock). We were unable to enroll any
participants who had the device for less than 1 year and who
had received a shock. The characteristics of these patients are
shown in Table 2. Four patients had a history of sudden
cardiac death. Patients in the group who had been shocked
each recalled only having been shocked once. All groups lasted
approximately 90 minutes.
None of the participants recalled ever having had a conver-
sation with their physician about deactivation, and no patient
knew that deactivation was an option. The moderators spent a
large portion of each focus group explaining to patients that, as
their health changed in the future, there might come a point at
which they would want the device deactivated.
In the course of these explanations, it became clear that
participants did not understand the role their ICD played in
their health. For example, instead of understanding that the
role of the device was to treat a potentially fatal arrhythmia,
one participant described his ICD as having a role in pacing his
heart, as follows:
I was given to understand that the defibrillator, one of
the jobs it does if the pacemaker falls asleep it will wake
it up, like a booster, you know what I mean? Like, ‘hey go
to work,’ you know what I mean? That’s what I was given
to understand.
(male participant, ICD<1 year, never shocked)
A patient in the same group described the role of the ICD as
only regulating rate and not the rhythm:
Well, I know that as my heart goes up to a certain level or
down to a certain level, it will go off. That’s all that I
understand.
(male participant, ICD<1 year, never shocked)
Patients also did not seem to fully understand the reason
they received their ICD. Instead of understanding the risk of
sudden cardiac death as the indication for needing an ICD, one
patient described the reason for implantation as related solely
to a change in heart rate:
WhenIcameformyannualphysicalrecently,theheartrate
had changed a little bit and they said, ‘Now you’re a
candidateforadefibrillator’andtheyputthedefibrillatorin.
(male participant,<1 year, never shocked)
Given the misinformation that most patients have about
their device, it is perhaps not surprising that many patients
came to the focus groups looking for more information, despite
the fact that when they were asked to participate they were
clearly told that it was neither a support or informational
group but instead part of a research study. One patient
described his desire to come to the group as:
This is the reason I’m here because I wanted to get other
people’s input...I want to know, ‘Hey, what can we do to
avoid that shock?’ That’s what I’m looking for.
(ICD<1 year, never shocked)
Another participant described his desire as
That’s what I really wanted to find out...what it feels like
for the device to go off. How tolerable is it?
(ICD>1 year, never shocked)
Similarly, patients who had been shocked were seeking
more information about their device and what to do when they
were shocked:
Right, more information as to what to do when you get
hit, what you can expect – there should be a whole list –
and what you do—that’s the other part. You don’t know
what the hell to do.
(ICD>1 year, received shock)
While explaining their (mis)understanding of their device,
participants in all groups described a great deal of anxiety
Table 2. Characteristics of Patients Enrolled in Focus Groups
Category Characteristic Value
Enrollment >1 year, no shock 2
>1 year, + shock 8
<1 year, no shock 5
Age Median (SD) 69 years (18.6)
Range 30–90 years
Ethnicity White, non-Hispanic 10
Hispanic/Latino 3
Asian 1
African-American 1
Sex Male 10
Education Less than high school 2
High school graduate 3
Some college 1
College graduate 4
Advanced degree 5
Indication
for ICD
At risk for sudden cardiac
death (primary prevention)
11
History of sudden cardiac
death (secondary prevention)
4
9 Goldstein et al.: Patients’ Attitudes Toward ICD Deactivation JGIMwhen thinking about future shocks from their device, regard-
less of whether they had previously experienced a shock. This
sense of anxiety is described in the following quotation from a
woman when she described an experience as a tourist passing
through a security screening:
I was in Pennsylvania, at the Liberty Bell, and the guys
were like, ‘Oh, just go through,’ and I had to fight with
them to be like, ‘I am not walking through that thing.
You’ve got to be crazy.’ They’re like, ‘It’s okay, it’s just this
and that’ and I’m like, ‘Do you understand what I’m
telling you?’ They don’t understand, they’re just like, ‘It’s
not a big deal’ and I’m like, ‘You get a shock, then tell me
it’s not a big deal.’
(ICD<1 year, never shocked)
Another participant who had the device for a longer period of
time describes a similar anxiety:
I’m very active and I’m concerned. Every time I drive to
work in the morning I ask myself what would happen if I
got a shock now, but thank God so far that hasn’t
happened.
(male participant, ICD>1 year, never shocked)
One patient who had received a shock also described a
similar sense of anxiety:
I was on my way to work and all of a sudden I got a blow
into my back...It was like someone took a medicine ball
and threw it with tremendous force into my back and I
turned around and asked some young fellow standing
there...‘Did you see what hit me?’...On the plus side, I
know it works. It saved my life. On the uh minus side, like
everybody else I think...that it scared me...it scared me
because it plays games with your head and you think
about it.
(male participant, ICD>1 year, had received shock)
In contrast to their willingness to talk about other issues
relating to their ICD, participants would not engage in
conversations about device deactivation during the focus
group, nor did they seem willing to have these conversations
with the clinicians who cared for them. When asked how he
would react to a physician raising the issue of device deacti-
vation, one participant stated:
That’s like an act of suicide. It’s a threat to your life.
That’s like cardiac arrest. That’s insane.
(male participant, ICD>1 year, never shocked)
A subject in another group (ICD>1 year, had received shock)
described deactivation as a “no-win situation,” but she would
not further characterize how she might consider turning off the
ICD. In fact, many patients could not contemplate any
situation in which death was a likely or probable outcome. As
described by one man:
The only solution to [the] problem that you pose is
probably a transplant...there has to be an alternate
solution—and I see transplant as being the only alter-
nate solution...I would never consider just shutting it off.
(male participant ICD>1 year, never shocked)
Another participant in this same group stated:
I would keep the defibrillator forever.
(male participant, ICD>1 year, never shocked)
Regardless of whether or not a participant had received a
shock from their device, all participants described the ICD as
only beneficial, with no burdensome aspect associated. As one
patient described:
For me, it’s like getting an extra life.
(female participant, ICD<1 year, never shocked)
This theme is illustrated even more clearly in the group of
patients who had been shocked. As one participant recounting
his doctor’s explanation at the time of implantation stated:
[My doctor said] you still have the [medical condition]...
And if it comes back in the bottom chamber of your heart
you just drop dead...We are going to suggest implanting a
defibrillator on you strictly as an insurance policy
basically. So that if it does come back you will be shocked
and you will be fine.
(male participant, ICD>1 year, had received shock)
Another participant in this same group anthropomorphizes
her ICD, almost describing the device as a trusted friend:
All I know is that it is there to help me and as long as I
don’t do wrong by it, it won’t do wrong by shocking me.
(female participant, ICD>1 year, had received shock)
The closest any participant would come to discussing
deactivation was describing their preferred role in decision
making about ICD deactivation. When asked about how he
might make a decision about deactivation, one participant
refused to answer and instead described his physician as the
one who should make such a decision:
That’s for your doctor to be the judge of that. If you have
something wrong with you, hey, you go right back to the
source. If you got a problem, go back to your doctor. He’s
the one who’ll tell you what to do and how to handle
yourself. You can’t do it on your own.
(ICD<1 year, never shocked)
As stated by a male patient in the same group,
I think that the doctor has to make that decision for you.
We’re all laymen, it isn’t for us to do that, that’s what
we’ve got doctors for.
Another patient expressed this theme in a slightly different
way, when he stated:
Do you always take your doctor’s advice? I find I have no
option [but to follow it].
(ICD>1 year, never shocked)
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Patients with ICDs in this qualitative study were uniformly
unaware that device deactivation was a decision that they
might face in the future. Furthermore, and despite multiple
prompts from the group facilitators, no participants were willing
to engage in advance care planning discussions regarding deacti-
vation—either during the focus group or with their own clinicians.
These results have important implications for advance care
planning as the number of people with ICDs is rapidly growing.
These results are markedly different from other research
examining patients’ willingness to engage in advance care plan-
ning. In the majority of other studies examining patients’ wishes
forcareattheendoflife,investigatorshavefoundthatpatientsare
quite open to discussing, and indeed want, to address treatment
o p t i o n sa n dg o a l so fc a r en e a rt h ee n do fl i f e .
23,24
There are several possible reasons for why our results differ
from other studies of advance care planning. First, ICDs are
fundamentally different from other interventions that patients
might receive at the end of life and those that have previously
been examined in other advance care planning studies. Unlike
mechanical ventilators, feeding tubes, and dialysis, ICDs are
typically implanted well before the patient perceives them-
selves to be seriously and terminally ill. That is, most patients
who receive an ICD are at risk for a fatal arrhythmia but are
not symptomatic from a serious illness that would place them
at high risk for a noncardiac death. Given the tremendous fear
of receiving a shock from the ICD expressed by patients in this
study, the inherent “emergency rescue” nature of the ICD, and
patients’ faith in the ICD’s life-restoring ability, it may be
impossible for otherwise “healthy” patients to envision a
situation when they would want this life-saving technology
withdrawn like they would for a hypothetical mechanical
ventilator or feeding tube.
Second, the participants in our study did not appear to fully
comprehend the nuances and intricacies of these devices. This
lack of knowledge may also inhibit their ability to engage in
conversations, as they may not have the knowledge necessary
to adequately weigh the option of deactivating the device. In
addition, the internalized and unseen nature of the device
makes it easier for patients to avoid conversations about them.
Third, patients appear to develop a complex psychological
relationship with their ICD in a way unlike other interventions.
The devices provide a sense of security (“like an insurance
policy” or like a trusted friend) and the very notion of removing
them is “like an act of suicide.” ICD discharges seem to be
psychologically destabilizing, as a shock “plays games” with
the patient’s emotional well being. It is somewhat paradoxical
that, in the same focus group, patients can acknowledge the
anxiety of getting shocked but nevertheless continued to speak
of the device as only beneficial. Participants seem to have
developed a symbiotic relationship with the device. If the ICD is
seen as a friend, then it is difficult for a patient to believe that
the device could actually do them any harm. The interplay of
these psychological factors results in a state of perceived
immortality for these participants—they will either get a new
heart or just keep their ICD “forever.”
Many of the participants in our study wanted their physi-
cian to make a decision about deactivation for them, and this
may be a phenomenon related to the fact that the participants
were all at a similar point in their overall state of health. The
research literature on decision making demonstrates that
patients’ desired role in decision making may change over the
course of their illness. For patients who are relatively healthy,
for whom the medical decisions are relatively simple, patients
want to either make the decisions themselves or share decision
making with their families.
25 As a patient’s illness progresses,
however, they go through a period of more complex decision
making where they desire less autonomy and want their
physician to make the decision for them.
25,26 Participants in
this study might be included in this category—the decision
about whether to deactivate the ICD is complex (both medically
and psychologically) given their current state of health, so at
the time of the interviews, patients ceded decision making to
their physician. As illness severity worsens and patients
approach the end of life, there are fewer options available,
and thus, decisions are simpler; the literature supports that
patients near the end of life desire to be more autonomous and
make decisions for themselves.
27,28 There are no data from
this study to show that these participants’ desired roles in
decision making will necessarily change as their health
worsens, so future work will need to examine this issue.
This study had several limitations that should be noted.
First, although all of the patients in this study had a serious
cardiac condition that required an ICD, they had an excellent
performance status and did not have other major comorbid
illnesses. It is possible that this might have created a selection
bias against patients who were more debilitated and may have
been more likely to contemplate their own mortality and the
changing role of the device. The participants in this study were
all drawn from a single academic medical center and may not
be representative of the larger population of patients with
ICDs. The majority of the patients included in this study were
male and white, which may limit the generalizability of these
findings. It should be noted, however, that disparities in
implantation have shown that women and minorities receive
these devices with less frequency than other groups.
29,30
Another potential limitation is that patients may either not
comprehend or not remember information that their physician
had told them,
31,32 so it is possible that some of the patients
included in this study may have previously been told that they
could have their ICD deactivated. Finally, a relatively small
number of patients were enrolled. The investigators chose not
to continue to enroll patients because it became apparent near
the end of the data analysis that no new concepts were
emerging from the data (i.e., thematic saturation had been
reached), but these finding will need to be further explored in
future larger, quantitative studies.
In this study of community-dwelling, ambulatory individuals
with ICDs, we found that patients were either unwilling or
unable to engage in conversations about deactivation. While the
goal ofthe studywas toidentify barriersthatcould beovercome,
what we found was that patients’ perceptions and understand-
ings of their device may be the most significant difficulty that
impedes them from engaging in discussions about the manage-
ment of the ICD. For clinicians who wish to have conversations
about these devices with patients near the end of life, one
approach might be to first elicit larger goals of care, and then
assist patients and families with a benefit/burden analysis to
determine how eachspecific treatment decision should bemade
in the context of their desires. Discussions about deactivating
ICDs can then be seen in the context of other goals of health
11 Goldstein et al.: Patients’ Attitudes Toward ICD Deactivation JGIMcare, thus helping patients understand that the decision to
deactivate the ICD may be a decision in-line with their overall
wishes as their illness progresses. Future work that involves
both qualitative and quantitative analyses is needed to create
communication interventions that will help physicians elicit
these larger goals of care and make ICD deactivation decisions
within this framework.
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